Common Types of Pharmaceutical Fraud

Recognize the Red Flags in the Pharmaceutical Industry

Skipping documentation or required protocols

Adulteration or contamination of pharmaceuticals resulting from noncompliance can put patient safety at risk and result in worthless care.

Off-Label Marketing

Non-prescriber encouragement or sales pitches to use prescription medication for purposes not included in the prescription insert can put patients at risk.

Failing to report loss of Controlled Substances

Reckless practices can result in diversion of addictive drugs, and failure to comply with mandatory reporting allows the risks to increase without correction.

Payments to third parties

Payment to third-party marketers, cappers, and runners based on the value or volume of healthcare billings may violate anti-kickback statutes and encourage deceptive practices.
Rx with cash and pills – GettyImages-1399981576
Know If You Have a Case

Examples of Pharmaceutical Fraud

  • Kickbacks or Stark Statute violations
  • Diversion of Controlled Substances
  • Fake prescriptions
  • Blanket Orders

Why Experience Matters

Why Experience Matters

Hirst Law Group has extensive experience helping whistleblowers with pharmaceutical fraud cases. Our past clients include compliance executives, pharmacists, licensed providers, pharmaceutical sales reps, medical billing professionals, patients, and more. 

Request Consultation

How Others Have Described Our Attorneys

Clients and legal professionals weighed in:

“Their work was truly outstanding, as was the support and guidance they provided to me. Hirst Law Group was fabulous!”

Client 19

“They made me feel heard, supported, and fought for me through the end. Excellent attorneys, but most importantly great human beings.”

Client 10

“Beyond their legal skill, their personal support made an immeasurable difference. I could not have navigated this process without them.”

Client 8

“Michael Hirst and his team are modern heroes.”

Client 3

“I highly recommend Hirst Law Group to anyone needing legal assistance. Words truly cannot convey just how much I appreciate the firm.”

Client 2

“An exceptional litigator who has performed a significant public service…  The successful outcome in this case significantly advanced the Department’s efforts to combat fraudulent health care practices.”

John Ashcroft
Former Attorney General of the United States

“Tireless efforts in preparation and brilliant performance at trial.”

Dale Bosworth
Former Chief of the United States Forest Service

A “quiet but tough negotiator.”

Stephen Klaidman
New York Times journalist and author, in his book "Coronary" (Simon and Schuster, 2007)